Vnitr Lek 2005, 51(5):499-500

Normoglykemie - terapeutický cíl pro diabetiky (i nediabetiky) v kritickém stavu - editorial

V. ©rámek
Anesteziologicko-resuscitační klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta prof. MUDr. Pavel ©evčík, CSc.

Received: April 25, 2004; Published: May 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©rámek V. Normoglykemie - terapeutický cíl pro diabetiky (i nediabetiky) v kritickém stavu - editorial. Vnitr Lek. 2005;51(5):499-500.
Download citation

References

  1. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol. Med Microbiol 1999; 26(3-4): 259-265. Go to original source... Go to PubMed...
  2. Bartáková H et al. Pneumologická problematika pacientů s diabetes mellitus. Vnitř Lék 2005; 51(5): 566-577.
  3. Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med 2004; 32(Suppl 4): S116-S125. Go to original source... Go to PubMed...
  4. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345(19): 1359-1367. Go to original source... Go to PubMed...
  5. Van den Berghe G, Bouillon R. Optimal control of glycemia among critically ill patients. JAMA 2004; 291(10): 1198-1199. Go to original source... Go to PubMed...
  6. Weekers F, Giulietti AP, Michalaki M et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003; 144(12): 5329-5338. Go to original source... Go to PubMed...
  7. Průcha M, Herold I, Zazula R et al. Monocytární deaktivace a produkce tumor nekrotizujícího faktoru-alfa ex vivo - prognostické paramentry u pacientů jednotek intenzivní péče. Anesteziologie a neodkladná péče 2003; 5: 223-227
  8. Payen D, Faivre V, Lukascewicz AC et al. Assesment of immunological status in the critically ill. Minerva Anesthesiol 2000; 66: 351-357.
  9. Nierhaus A, Schneider CG, Frings D et al. Sequential assessment of immune function in SIRS and sepsis: monocyte function, severity and outcome. Intensive Care Med 2001; 27(Suppl 2): S199.
  10. Nierhaus A, Montag B, Timmler N et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 2003; 29(4): 646-651. Go to original source... Go to PubMed...
  11. Kox WJ, Bone RC, Krausch D et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med 1997; 157(4): 389-393. Go to original source...
  12. Boelens PG, Houdijk AP, Fonk JC et al. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 2002; 132(9): 2580-2586. Go to original source... Go to PubMed...
  13. Moss M, Guidot DM, Steinberg KP et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000; 28(7): 2187-2192. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.